Genomics of HIV/AIDS Drug Response and Co-Morbidities
The purpose of this funding opportunity announcement is to expand the use of high-throughput genotyping, genomic sequencing, and related genomic technologies, and generate resulting data resources widely available for research use, to improve the efficacy and safety and ease of use of HIV/AIDS therapies and of non-HIV drugs used to treat HIV/AIDS patients, and to reduce HIV/AIDS-related comorbidities, coinfections, and complications.
- Pre-Application Submission: 30 days before application submission due date
- Application Submission: 5:00 PM local time of applicant organization, May 7, 2017; Sep. 7, 2017; Jan. 7, 2018; May 7, 2018; Sep. 7, 2018; Jan. 7, 2019; May 7, 2019; Sep. 7, 2019; Jan. 7, 2020
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.